A COMPARATIVE STUDY ON RISK ANALYSIS IN MULTIDRUG-RESISTANT TUBERCULOSIS POPULATION OF TELANGANA STATE (INDIA)
- At: 2015 FIP Congress in Düsseldorf (Germany)
- Type: Presentation
- By: BOMPELLI, Anusha (St. Peter's Institute of Pharmaceutical Sciences, Pharmacy Practice, Hanamkonda, India)
- Co-author(s): Anusha Bompelli
The previous treatment for tuberculosis (TB) is the strongest risk factor for development of multidrug-resistant (MDR) TB. The current scenario states that even treatment naïve patients are also at risk. It is necessary to identify the group at high risk.
A prospective observational study was carried out over a period of 9 months in govt... The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.